10 results
8-K
EX-99.1
IMVT
Immunovant Inc
8 Dec 22
Regulation FD Disclosure
7:06am
Demyelinating Polyneuropathy; EAN/PNS = European Academy of Neurology/Peripheral Nerve Society; Ig = immunoglobulin (IVIG and SCIG) therapy; IMP
8-K
EX-99.1
IMVT
Immunovant Inc
7 Sep 22
Regulation FD Disclosure
6:39am
of Neurology/Peripheral Nerve Society; Ig = immunoglobulin (IVIG and SCIG) therapy; IMP = investigational medicinal product; LTE = Long-term Extension
DEFA14A
EX-99.1
IMVT
Immunovant Inc
29 Oct 19
Additional proxy soliciting materials
1:50pm
be the optimal outcome for society and for shareholders. I would think this is more likely to be the case now than at any time in the last couple of decades
8-K
EX-99.1
IMVT
Immunovant Inc
29 Oct 19
This report is prepared solely for the use of John Strumbos
1:48pm
be the optimal outcome for society and for shareholders. I would think this is more likely to be the case now than at any time in the last couple of decades
424B4
h7itx um8wzi7d1
10 May 19
Prospectus supplement with pricing info
5:18pm
S-1
h76ml5g8xntyy0i
15 Apr 19
IPO registration
9:56pm
DRS/A
fh61yd2e2ijnehhor6o
26 Feb 19
Draft registration statement (amended)
12:00am
DRS
5vee9lv
23 Jan 19
Draft registration statement
12:00am
- Prev
- 1
- Next